BioSpace News Archive

Konica Minolta Healthcare Americas, Inc., a recognized leader in medical imaging systems and healthcare IT, announces the latest release of AeroRemote® Insights, a cloud-based, business intelligence and analytics solution that delivers detailed information on asset utilization, department efficiency, imaging system health and more.

Echolight Medical, manufacturer of the innovative EchoS, which can diagnose osteoporosis and assess a person’s risk for the disease within minutes without radiation, is broadening global operations with the opening of its United States headquarters in Seattle.

RSIP Vision, a global supplier of medical artificial intelligence (AI), computer vision and image processing technology, has announced the release of an innovative new AI bone segmentation and landmark detection module that will dramatically improve pre-operative planning, intraoperative guidance, and post-operative patient experience in knee replacement surgery.

Curi Bio , a leading developer of human stem cell-based platforms for drug discovery, today announced the Mantarray™ platform for human-relevant 3D engineered muscle tissue (EMT) analysis. Curi’s Mantarray platform enables the discovery, safety, and efficacy testing of new therapeutics by providing parallel analysis

Starpharma (ASX: SPL, OTCQX: SPHRY), based in Melbourne, Australia, today announced that Dr Jackie Fairley, Chief Executive Officer, will present a pre-recorded presentation at LifeSciencesInvestorForum.com on September 17 th . DATE: Thursday, September 17 th TIME: 9:30 AM ET LINK: https://bit.ly/30GjErk If attendees are not able to join the event live on the day of the conference, an archived webcast will also be ma

Rhino Novi Inc. is pleased to announce that it has completed its corporate action and changed its name from Rhino Novi Inc. to BioLife Sciences Inc., and its ticker symbol from “RNOV” to “BLFE”.

Ryvu Therapeutics (WSE: RVU), a clinical-stage biopharmaceutical company developing novel small molecule therapies that address emerging targets in oncology, reported today its 2020 H1 financial results and provided a corporate update. " At Ryvu, we always excelled in moving forward at a rapid pace; however, the first half

An early study in human cells found that an antiviral drug candidate, Pfizer Inc.'s PF-00835231, may be at least as potent as the drug remdesivir in blocking the reproduction of the virus that causes COVID-19.

Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today announced the addition of Nancy Vitale as an independent director to its Board of Directors, effective as of September 15, 2020. Ms. Vitale brings more than 25 years of experience to Voyager’s Board, with deep expertise in human resources. She is a former Senior Vice President

Viemed Healthcare, Inc. (the “ Company ” or “ Viemed ”) (TSX:VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced today that it has been invited to present at Lake Street’s 4 th Annual Best Ideas Growth (BIG4) Conference, being held on Thursday, September 17, 2020, on a virtual platform. Viemed’s management, Casey Hoyt, CEO and Todd Zehnder, COO, are sch